Navigation Links
Karen Walton-Bowen Joins Abt Bio-Pharma Solutions, Inc., as Senior Director, Biometrics
Date:10/22/2008

CAMBRIDGE, Mass., Oct. 22 /PRNewswire/ -- Karen Walton-Bowen, M.Sc., C.Stat, a biostatistician with more than 20 years experience in the pharmaceutical and biotechnology industries, has joined Abt Bio-Pharma Solutions, Inc. (ABS), as Senior Director, Biometrics. An expert in clinical trials and regulatory submissions in all phases of clinical development across multiple therapeutic areas, Ms. Walton-Bowen's experience encompasses clinical operations, data management, programming, statistical support, and medical writing, both in the U.S. and in Europe. In addition to leading ABS' full service Biometrics team, she will work one-on-one with sponsors to provide sophisticated biostatistics and medical writing consulting services for registries and late-phase clinical trials.

"Karen's strong technical and project management skills will make her a 'go to' resource for our small- to medium-size clients who wish to extend their capabilities with direct access to an hands-on expert with broad and deep therapeutic area experience," said Dr. Kay Larholt, Vice President of Biometrics & Clinical Operations. "We also expect Karen to add value and strengthen our already accomplished Biometrics team as it continues to support all our clinical projects, including clinical trials and registries."

Prior to joining ABS, Ms. Walton-Bowen was most recently Senior Director of Clinical Operations, Biostatistical Analysis, and Reporting at Critical Therapeutics, Inc. Previously, she spent four years at Genzyme Corporation, where she led the Biometrics team in a successful BLA submission and FDA Advisory Panel approval of a drug for a rare life-threatening disease in children. Ms. Walton-Bowen also spent many years at Astra (in the US and Sweden) as a biostatistician working on different compounds in the respiratory business unit. During that time she submitted numerous NDAs and represented the company at FDA meetings and Advisory Panels.

Ms. Walton-Bowen was awarded her M.Sc. in Medical Statistics by the University of London and earned her B.S. degree with honors in Mathematics & Computing from South Bank University, London, England. She is a member of the Royal Statistical Society, American Statistical Association, Drug Information Association, and the Association of Clinical Research Professionals. Ms. Walton-Bowen's work has been published in leading journals including Statistics In Medicine, The Journal of Pediatrics, and Annals of Allergy, Asthma & Immunology. She was also a contributor to Biopharmaceutical Sequential Statistical Applications, an important textbook on interim analyses with contributions from industry leaders.

The ABS team has provided integrated strategic, research, and commercialization services to the pharmaceutical, biotechnology, medical device, and diagnostics industries for more than 20 years. The company specializes in demonstrating the value, safety, and efficacy of health technologies through prospective studies such as registries as well as through retrospective data analyses, models, and quantitative and qualitative research. ABS teams of senior, seasoned staff help sponsors develop their research agendas, successfully conduct their research programs, and communicate the results to internal and external audiences. Primary service offerings include biometrics, clinical trials, registries and other late-phase clinical studies, health economics and outcomes research, pricing and reimbursement, and strategic commercialization services. Previously known as Abt Associates Clinical Trials, the company was renamed Abt Bio-Pharma Solutions and established as a wholly owned subsidiary of Abt Associates in April 2008.


'/>"/>
SOURCE Abt Bio-Pharma Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Health Monitoring Systems Appoints Karen S. Dockrell As VP, Sales
2. Food and Beverage Giant Joins Kannapolis Research Center
3. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
4. Chief Technology Officer Joins ACAMP
5. Charles C. Harwood, Jr., Joins Cellectar, Inc.s Board of Directors
6. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
7. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
8. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
9. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
10. GM Exec Joins Bio-Reaction Industries Board of Directors
11. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... From industry leaders, sports stars, and Hollywood ... failed. Many of these people had lost all hope. Their stories are ... Download (pdf) , “Neil takes readers on a riveting journey through the ...
(Date:9/19/2017)... Charleston, SC (PRWEB) , ... September 19, 2017 ... ... Express, safely and accurately automates the most dangerous step of sample prep for ... digestion system to provide automation at an affordable price. The system is ideal ...
(Date:9/19/2017)... Poway, CA (PRWEB) , ... September 19, 2017 , ... VetStem Biopharma ’s CEO ... H. Riordan PA, PhD in Riordan’s new book "Stem Cell Therapy: A Rising Tide". ... past 14 years. They bonded over an interest in the potential of stem cell ...
(Date:9/19/2017)... FRANCISCO , Sept. 19, 2017 ValGenesis ... Solutions (VLMS) is pleased to announce the strategic partnership ... to provide clients with validation services using the latest ... partner, VTI will provide clients with efficient and cost-effective ... a marketing partner for the ValGenesis VLMS system. ...
Breaking Biology Technology:
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
Breaking Biology News(10 mins):